Federal Register Notice: FDA has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. It will allow the agency to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements. These products include Teligent Pharmaceutical’s Aquamephyton, Merck’s Clinoril, Luitpold Pharmaceutical’s Furosemide, and Schering-Plough’s Normodyne. To view this notice, click here.